| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 01/08/2008 | CA2267315C Ethylamine derivatives |
| 01/08/2008 | CA2225830C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 01/08/2008 | CA2172513C Aminocyclohexylesters and uses thereof |
| 01/03/2008 | WO2008002583A1 Glycine transporter-1 inhibitors |
| 01/03/2008 | WO2008000834A1 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds |
| 01/03/2008 | WO2008000438A1 Insecticidal compounds |
| 01/03/2008 | WO2008000410A1 Cxcr2 inhibitors |
| 01/03/2008 | WO2008000409A1 New cxcr2 inhibitors |
| 01/03/2008 | WO2005044008A3 2 -aminothiophene compounds as fungicides |
| 01/03/2008 | US20080004415 Non-linear optically active molecules, their synthesis, and use |
| 01/03/2008 | US20080004334 Thiolactones |
| 01/03/2008 | US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 01/03/2008 | US20080004301 Benzene Compound Having 2 or More Substituents |
| 01/03/2008 | US20080004290 Anti-Cancer Agents |
| 01/03/2008 | US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/03/2008 | CA2656150A1 New cxcr2 inhibitors |
| 01/03/2008 | CA2655404A1 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds |
| 01/03/2008 | CA2655159A1 Glycine transporter-1 inhibitors |
| 01/02/2008 | EP1873136A1 Method for manufacturing alkyl and aryl ethers |
| 01/02/2008 | EP1871744A1 New heterocyclylethylbenzamide derivatives |
| 01/02/2008 | EP1871379A2 Cyanoarylamines |
| 01/02/2008 | EP1539731B1 Novel compounds |
| 01/02/2008 | EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 01/02/2008 | EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 01/02/2008 | EP1406859B1 Substituted 4-aminocyclohexanol derivatives |
| 01/02/2008 | EP1268404B1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 01/02/2008 | CN101098863A Method for purifying (1s)-3-methylamino-1-(2-thienyl)-1-propanol |
| 01/02/2008 | CN101098852A Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof |
| 01/02/2008 | CN101098845A 6-phenylhex-5-enoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 01/02/2008 | CN101096593A Organometallic compounds and emission-shifting organic electrophosphorescence |
| 01/02/2008 | CN101096592A Organometallic compounds and emission-shifting organic electrophosphorescence |
| 01/02/2008 | CN101096359A Polyarylsubstituted methane oxygen or silica radical guanidine compound and preparation method and usage thereof |
| 01/02/2008 | CN100358887C M-aminophenol derivatives and coloring agents containing them |
| 01/01/2008 | US7314932 Methods for minimizing thioamide impurities |
| 01/01/2008 | US7314929 Organoselenium compounds for cancer chemoprevention |
| 01/01/2008 | US7314875 Tricyclic aromatic and bis-phenyl sulfinyl derivatives |
| 01/01/2008 | US7314874 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide;modified amidine elements of high potency in vitro, excellent pharmacological and pharmaceutical properties in vivo |
| 01/01/2008 | US7314870 Compounds, their preparation and use |
| 12/27/2007 | WO2007148103A1 Crystalline duloxetine hydrochloride |
| 12/27/2007 | WO2007148102A2 Crystalline duloxetine hydrochloride |
| 12/27/2007 | WO2007148096A1 Crystalline duloxetine hydrochloride |
| 12/27/2007 | WO2007147822A1 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 12/27/2007 | WO2004058735A3 Ligands of melanocortin receptors and compositions and methods related thereto |
| 12/27/2007 | US20070299263 Hydroxy Alkyl Amines |
| 12/27/2007 | US20070299129 Compounds and derivatives for the treatment of medical conditions by modulating hormone-sensitive lipase activity |
| 12/27/2007 | US20070299114 Biaryl Derivatives |
| 12/27/2007 | US20070299107 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 12/27/2007 | US20070299093 Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation |
| 12/27/2007 | US20070299080 Benzamide derivatives and uses related thereto |
| 12/27/2007 | US20070299074 Guanidine Compounds, and Use Thereof as Binding partners for 5-Ht5 Receptors |
| 12/27/2007 | US20070298984 Lubricant Compositions Containing Seal Conditioning Agents |
| 12/27/2007 | CA2657967A1 Cyclopentane derivatives as antiglaucoma agents |
| 12/27/2007 | CA2656035A1 Crystalline duloxetine hydrochloride |
| 12/27/2007 | CA2655991A1 Crystalline duloxetine hydrochloride |
| 12/27/2007 | CA2655962A1 Crystalline duloxetine hydrochloride |
| 12/27/2007 | CA2655728A1 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 12/26/2007 | EP1869009A1 New bicyclic angiotensin ii agonists |
| 12/26/2007 | EP1869008A1 Inhibitors of prolyl endopeptidase |
| 12/26/2007 | EP1868983A1 Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols |
| 12/26/2007 | EP1597248B1 Sulfonamide derivatives as ppar modulators |
| 12/26/2007 | EP0804428B1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 12/26/2007 | CN101094845A Substituted thiophenes |
| 12/26/2007 | CN101092412A Ion liquor in onium category of tetrahydrothiophene, preparation method, and application |
| 12/26/2007 | CN101092411A Industrialized preparation method for 5 ¿C formoxyl ¿C 3 - ester thiohenic acid |
| 12/26/2007 | CN100357304C Diarene compound, its preparation method and application |
| 12/26/2007 | CN100357274C Diaryl-enynes |
| 12/25/2007 | US7312336 Ligands for the delta opiod receptor; novel compounds which possess a piperidine ring with an exocyclic double bond do not show significant convulsive effects when administered systemically |
| 12/25/2007 | US7312245 controlling harmful drug resistant fungi at lower concentrations; safe for crops; rice blast |
| 12/25/2007 | US7312214 Anticoagulants; atherosclerosis; strokes; thrombosis; cardiovascular disorders |
| 12/25/2007 | US7312179 Cyclopropyl-thienyl-carboxamide as fungicides |
| 12/21/2007 | WO2007144637A1 2 -oxyheteroarylamide derivatives as parp inhibitors |
| 12/21/2007 | WO2007123900A3 Enantiomers of n,n-dimethyl-3-(2-thienyl)-3-hydroxypropanamine borane as intermediates in the synthesis of duloxetine |
| 12/21/2007 | WO2007093529A3 Heteroaroyl-substituted alanines |
| 12/21/2007 | WO2007001225A8 Thiophene-2-carboxamide derivatives as alpha 7 nicotinic receptor modulators. |
| 12/21/2007 | WO2006108792A8 New heterocyclylethylbenzamide derivatives |
| 12/21/2007 | WO2006103342A8 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 12/21/2007 | WO2004002981A3 Herbicidal thienylalkynes |
| 12/21/2007 | CA2655146A1 Benzamide derivatives and uses related thereto |
| 12/20/2007 | US20070293561 5-{3-[(1S,5S)-5-(3-Chloro-5-hydroxymethyl-phenoxymethyl)-4-oxo-cyclopent-2-enyl]-propyl}-thiophene-2-carboxylic acid; Treating eye diseases including glaucoma or ocular hypertension; selective prostaglandin EP2 agonists |
| 12/20/2007 | US20070293560 Compounds and compositions |
| 12/20/2007 | US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 12/20/2007 | US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa |
| 12/20/2007 | US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine |
| 12/20/2007 | US20070293486 Alpha-Keto Carbonyl Calpain Inhibitors |
| 12/20/2007 | US20070292768 Comprises arylsulfonyloxime; for integrated circuits; suited for deep UV lithography; improved in pattern profile shape particularly when the thickness of resist film is reduced |
| 12/20/2007 | US20070289625 -Conjugated Mono-, Oligo-and Polymeric Compounds, and Photovoltaic Cells Comprising Them |
| 12/19/2007 | EP1867651A1 Semi-conducting coatings containing organic linear thiophen-phenyl oligomers |
| 12/19/2007 | EP1867633A1 Polyamine analogues as therapeutic and diagnostic agents |
| 12/19/2007 | EP1866300A1 Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists |
| 12/19/2007 | EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/19/2007 | EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 12/19/2007 | EP1032556B1 Pharmaceutically active compounds and methods of use |
| 12/19/2007 | CN101090897A Novel fused ring compounds, and their use as cationic photoinitiators |
| 12/19/2007 | CN101090896A Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents |
| 12/19/2007 | CN101090883A Substituted hydroxyethylamines |
| 12/19/2007 | CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof |
| 12/18/2007 | US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 12/18/2007 | CA2219070C Methods of preventing breast cancer |
| 12/13/2007 | WO2007142228A1 Smectic liquid crystal compound |
| 12/13/2007 | WO2007141504A1 Fused thiophene derivatives as kinase inhibitors |